Capri Medical is targeting a procedural shift in neuromodulation by enabling injectable, wireless implants that move nerve stimulation into outpatient settings, reducing surgical burden. This minimally invasive approach positions it between traditional implantable systems and external wearables, though it remains early-stage with no clinical validation yet.